DRUG INDUCED LIVER INJURY
Hosted by JC Fernández-Checa
This LiverSeminar will focus on DILI in the context of obesity and NAFLD.
Visits will always have the same agenda: during the morning, the Expert will be able to meet in private with scientists from research centres geographically close to the Institution that welcomes him (please book your time slot at the “meet the speaker” tab), in the afternoon we will have the seminar itself that will be live broadcasted to the Institute that does not host the speaker.
Please note that activities are not restricted to the personnel from the organizing institutions. In this page you will find detailed information about the invited Speakers and scientific topics that will be covered during this academic year.
PharmD and PhD, is a research director at INSERM, the French Institute of Health and Medical Research. For 15 years, Dr Fromenty worked in Dr Pessayre’s lab in Paris but in 2008 he moved to the INSERM unit 1241 (NUMECAN Institute) in Rennes. In this Institute, Dr Fromenty is codirecting the team EXPRES (Exogenous/endogenous stress and pathological responses in hepato-gastrointestinal diseases), working more specifically on xenobiotic-induced hepatotoxicity. Indeed, Dr Fromenty has been working since 1990 on drug- and ethanol-induced mitochondrial dysfunction, oxidative stress and liver diseases, with a particular focus on steatosis and steatohepatitis. More recently, his investigations extended to the modulation of drug-induced hepatotoxicity in obesity and nonalcoholic fatty liver disease (NAFLD). He is the co-author of 107 original or review publications.
Find below the video recording as soon as it is available.